Furthermore, patients with IDH mutant glioblastomas showed longer survival than patients with glioblastomas, or even anaplastic astrocytomas, without IDH mutations [18, 21, 22, 34, 35]. This evidence concerns the gene IDH1 and anaplastic astrocytoma.